SEC Form 8-K Summary
Registrant: Wealthbridge Acquisition Limited, a British Virgin Islands special purpose acquisition company; the provided metadata identifies Scienjoy Holding Corp., but Scienjoy is not named as the registrant in this filing.
Reporting date: February 5, 2019; the IPO closed on February 8, 2019, and the report was signed on February 11, 2019.
Business Context and Transaction
The SEC declared effective the registration statement for Wealthbridge’s initial public offering. The company entered into its underwriting, warrant, rights, trust, escrow, registration rights, and related shareholder agreements in connection with the IPO.
Wealthbridge is a blank-check company formed to pursue an initial business combination. The filing does not identify an operating business or completed acquisition.
Key Financial and Capital Metrics
- IPO: 5,000,000 units sold at $10.00 per unit.
- Gross IPO proceeds: $50.0 million.
- Each unit included one ordinary share, one warrant to purchase one-half of an ordinary share at $11.50 per whole share, and one right to receive one-tenth of an ordinary share upon an initial business combination.
- Private placement: 247,500 units sold to the sponsor at $10.00 per unit.
- Private placement proceeds: $2.475 million.
- As of February 8, 2019, $50.0 million of net IPO and private placement proceeds had been deposited in a trust account for public shareholders.
- Underwriters received a 45-day option to purchase up to 750,000 additional units for over-allotments.
- Chardan Capital Markets received an option to purchase up to 375,000 units at $11.50 per unit, exercisable beginning on the later of the business-combination closing and six months after the registration statement’s effectiveness.
The filing does not provide revenue, net income, operating cash flow, margins, debt balances, or liquidity ratios. An audited balance sheet as of February 8, 2019 was to be filed separately within four business days after the IPO closing.
Material Changes and Unusual Items
- The registration statement became effective and the IPO and sponsor private placement were completed.
- Private-placement warrants have different terms from public warrants, including non-redeemability and cashless exercise while held by the initial purchasers or permitted transferees.
- Private-unit holders received specified demand and piggyback registration rights and agreed to transfer restrictions generally lasting until completion of the initial business combination.
- No prior comparable operating period or financial performance comparison is presented.
Outlook, Risks, and Contingencies
- The company’s funds are principally held in trust pending an initial business combination and related shareholder rights.
- The filing does not provide management guidance, acquisition targets, timing estimates, or operating forecasts.
- Completion of a future business combination, exercise or redemption of warrants, over-allotment activity, and use of trust-account proceeds remain contingent.
- The filing includes contractual restrictions and special terms applicable to sponsor securities, which may affect future dilution and trading liquidity.
Investor Verification Items
- Verify the registrant’s identity and relationship, if any, to Scienjoy Holding Corp.; the filing names Wealthbridge Acquisition Limited.
- Review the subsequently filed audited balance sheet and financial statements for actual cash, offering costs, liabilities, and trust-account balances.
- Confirm whether the underwriters exercised any portion of the 750,000-unit over-allotment option.
- Review the warrant, rights, escrow, trust, and registration-rights agreements for dilution, redemption, transfer, and business-combination provisions.
- Track subsequent filings for the proposed or completed initial business combination and any changes to the trust account.